Severe cognitive impairment

Kodiak Sciences to Present at the 41st Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Wednesday, January 4, 2023
ABC, Patient, PALO, Severe cognitive impairment, IL-6, KOD, Conference, Glaucoma, AMD, Therapy, VEGF, Science, Retina, Research, Pharmaceutical industry

Kodiak (Nasdaq: KOD) is a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases.

Key Points: 
  • Kodiak (Nasdaq: KOD) is a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases.
  • Kodiak has leveraged its ABC Platform to build a pipeline of product candidates in various stages of development.
  • KSI-501 is our dual inhibitor antibody biopolymer conjugate targeting both VEGF (VEGF-trap) and IL-6 (anti-IL-6 antibody) for the treatment of retinal diseases.
  • Kodiak®, Kodiak Sciences®, ABC™, ABC Platform™ and the Kodiak logo are registered trademarks or trademarks of Kodiak Sciences Inc. in various global jurisdictions.

Braille Institute Celebrates 4th Annual "Assistive Technology Month" In January

Retrieved on: 
Wednesday, January 4, 2023
Freedom Scientific, Braille Institute of America, Connecting Point Group, Microsoft, Multimedia, Macular degeneration, Severe cognitive impairment, Airport, Television, Satellite navigation device

LOS ANGELES, Jan. 4, 2023 /PRNewswire/ -- Braille Institute celebrates January as "Assistive Technology Month" with over 10 free educational and interactive online technology workshops featuring speakers from the field, as well as hands-on device presentations and demonstrations.

Key Points: 
  • LOS ANGELES, Jan. 4, 2023 /PRNewswire/ -- Braille Institute celebrates January as "Assistive Technology Month" with over 10 free educational and interactive online technology workshops featuring speakers from the field, as well as hands-on device presentations and demonstrations.
  • "Assistive technology can be a real game changer for those who are blind or visually impaired.
  • With Braille Institute centers now re-opened for in-person services, attendees have two options for free workshop instruction.
  • Anyone requiring assistance or technology training can receive free one-on-one technology help from Braille Institute's Connection Pointe staff at any of the seven Southern California locations.

Iveric Bio Announces Completion of Rolling NDA Submission to FDA for Avacincaptad Pegol for the Treatment of Geographic Atrophy

Retrieved on: 
Tuesday, December 20, 2022
Biotechnology, FDA, Pharmaceutical, Health, ISEE, EMA, Blood, Security (finance), Patient, Atrophy, Food, IOP, ACP, CNV, Disease, Geographic atrophy, FDA Special Protocol Assessment, Retina, Growth, Endophthalmitis, Marketing, FDA, Safety, Inflammation, Clinical trial, C5, AMD, Ageing, NDA, European Medicines Agency, Severe cognitive impairment, Vasculitis, Breakthrough therapy, Scar, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Chemistry, Pharmaceutical industry

Per the company’s agreement with the FDA for rolling NDA review, part 3 of the NDA included chemistry, manufacturing, and controls data.

Key Points: 
  • Per the company’s agreement with the FDA for rolling NDA review, part 3 of the NDA included chemistry, manufacturing, and controls data.
  • “We are excited to have submitted our complete NDA for avacincaptad pegol with a request for priority review based on our Breakthrough Therapy designation,” said Glenn P. Sblendorio, Chief Executive Officer of Iveric Bio.
  • In addition, ACP is the first and only investigational therapy to receive Breakthrough Therapy designation for GA secondary to AMD.
  • There are currently no U.S. FDA or European Medicines Agency (EMA) approved treatment options available for patients with geographic atrophy secondary to AMD.

Insights on the Pet Diabetes Care Global Market to 2027 - Growing Pet Humanization Worldwide Fuels Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, December 19, 2022
Health, Veterinary, Pets, Consumer, Dementia, UTI, Internet of things, IOT, Glucose, Tissue, Dog, Obesity, Health, Livestock, Diabetes, Animal, Hospital, R, Prevalence, Government, Parent, Allergy, Severe cognitive impairment, Artificial intelligence, Cat, Urinary tract infection, Insulin, Research, PETS, Machine learning, Pet, Medical device, Medical imaging, Growth

The "Pet Diabetes Care Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Pet Diabetes Care Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
  • The global pet diabetes care market size reached US$ 1.71 Billion in 2021.
  • Looking forward, the publisher expects the market to reach US$ 2.76 Billion by 2027, exhibiting a CAGR of 8.31% during 2021-2027.
  • Apart from this, the rising accessibility of pet diabetes care, along with a growing number of veterinary professionals, clinics, and hospitals, is propelling the market growth.

Prevent Blindness Invites Patients and Caregivers to Join The Glaucoma Community as Part of January's National Glaucoma Awareness Month

Retrieved on: 
Tuesday, December 27, 2022
Well, Internet, Patient, BrightFocus Foundation, Severe cognitive impairment, Eastern Virginia Medical School, National Medical Association, Assistant, Optic nerve, Peripheral vision, Risk, NMA, Glaucoma, Korea Disease Control and Prevention Agency, MD, News, Visual impairment, Caregiver, Research, MSCE, Online shopping, Pharmaceutical industry, Ophthalmology

CHICAGO, Dec. 27, 2022 /PRNewswire-PRWeb/ -- As part of January's National Glaucoma Awareness Month, Prevent Blindness, the nation's leading voluntary eye health nonprofit organization, is offering a wide variety of free resources to help glaucoma patients and their caregivers find the support they need to address the many aspects of the eye disease.

Key Points: 
  • Non-profit group Prevent Blindness offers a variety of free glaucoma educational resources, including "The Glaucoma Community," to patients with the eye disease and their caregivers.
  • Prevent Blindness offers " The Glaucoma Community ," supported by Responsum Health , providing users with a free toolkit of helpful, community-oriented features.
  • All Glaucoma Community content is written by professional health writers and reviewed by the Expert Advisory Council for The Glaucoma Community .
  • Lastly, Prevent Blindness offers the newly updated Living Well With Low Vision resource, designed for patients, caregivers, and healthcare professionals.

Gabriel Groisman Elected Chairman of the Board of the Children's Tumor Foundation

Retrieved on: 
Monday, December 26, 2022
NF, Partner, Centre for Social Justice Awards, Patient, Chairperson, Neoplasm, Severe cognitive impairment, Deafness, Hope, Neurofibromatosis, University, Children's Tumor Foundation, CTF, Learning, Schwannomatosis, JD, Government, National Executive Committee of the Labour Party, Executive Committee, Chair, Pursuit, Research, Cancer, Jewish Community Relations Council of Minnesota and the Dakotas, Radio, Volunteering, Pharmaceutical industry, Medicine, Hotel, Jews, Philosophy, Jurist

NEW YORK, Dec. 26, 2022 /PRNewswire-PRWeb/ -- The Board of Directors of the Children's Tumor Foundation (CTF) has unanimously elected Gabriel Groisman of Bal Harbour, Florida, as Chairman of the Board. First elected to the CTF Board in 2016, Mr. Groisman most recently served the Foundation as Vice-Chairman of the Board, and previously as Secretary. He has also served as Chair of the Community Relations and Government Engagement Committee of the Board.

Key Points: 
  • The Board of Directors of the Children's Tumor Foundation (CTF) has unanimously elected Gabriel Groisman of Bal Harbour, Florida, as Chairman of the Board.
  • NEW YORK, Dec. 26, 2022 /PRNewswire-PRWeb/ -- The Board of Directors of the Children's Tumor Foundation (CTF) has unanimously elected Gabriel Groisman of Bal Harbour, Florida, as Chairman of the Board.
  • First elected to the CTF Board in 2016, Mr. Groisman most recently served the Foundation as Vice-Chairman of the Board, and previously as Secretary.
  • "I am deeply grateful and humbled to have the support of the Board of the Children's Tumor Foundation to serve as its Chair," said Gabriel Groisman.

The Global Ocular Trauma Devices Market size is expected to reach $5.3 billion by 2028, rising at a market growth of 6.7% CAGR during the forecast period

Retrieved on: 
Thursday, December 22, 2022
Blast-related ocular trauma, Precision, Johnson & Johnson, Bausch Health, Trauma, Patient, Travel, EssilorLuxottica, Cataract, Explosion, Eye, Field line, Growth, CooperVision, COVID-19, Diagnosis, Scotoma, Common, Severe cognitive impairment, Eyelid, Visual impairment, Glaucoma, COOPER, Alcon, Ageing, Riot, Ophthalmology, Incidence, Carl Zeiss AG, War, Hoya Corporation, Hospital, Injury, Telescopic sight, Medical device

View original content:https://www.prnewswire.com/news-releases/the-global-ocular-trauma-device...

Key Points: 
  • NEW YORK, Dec. 22, 2022 /PRNewswire/ -- The Global Ocular Trauma Devices Market size is expected to reach $5.3 billion by 2028, rising at a market growth of 6.7% CAGR during the forecast period.
  • Ocular trauma devices are equipment utilized in the management of ocular trauma that is caused by injuries to the area around the eyes including the eyes and eyelids.
  • Since a specified description of ocular trauma does not exist, based on the institutions, ocular injuries and their symptoms can be described more inclusively.
  • On the basis of indication, the ocular trauma devices market is divided into blunt trauma, chemical trauma, and sharp trauma.

Eyebuydirect Names Three-Time Paralympian Colleen Young Winner of 2022 Eye Care Awards

Retrieved on: 
Tuesday, December 20, 2022
Albinism, Swimming, Individual, EssilorLuxottica, Love, Silver, Severe cognitive impairment, Computer, Human, Swimming at the 2008 Summer Olympics – Event Order, Multimedia, Personality, Young, Visual impairment, Dream, United States national team, Disability, Colleen Young, CAD, Toy, Online shopping, Paralympic Games, EyeBuyDirect

LOS ANGELES, Dec. 20, 2022 /PRNewswire/ -- Eyebuydirect, the leading online retailer for prescription eyewear, is honoring Colleen Young, a silver and bronze Paralympic medalist, for her achievements as an athlete, role model, and champion for eye health with the second annual Eyebuydirect Eye Care Award. Young will receive a $25,000 contribution from Eyebuydirect, funds that will be used to support Young's training efforts toward competing in the 2024 Paris Paralympics, her fourth Olympic event. Young fell in love with swimming competitively and, at 14, became the youngest athlete to compete for Team USA in 2012. She continued to make incredible breakthroughs for the sport, holding three USA Paralympian world records.   

Key Points: 
  • LOS ANGELES, Dec. 20, 2022 /PRNewswire/ -- Eyebuydirect , the leading online retailer for prescription eyewear, is honoring Colleen Young , a silver and bronze Paralympic medalist, for her achievements as an athlete, role model, and champion for eye health with the second annual Eyebuydirect Eye Care Award.
  • Now, it's so important to me to fill that void for other people impacted by Albinism or other vision-related conditions," said Colleen Young.
  • With this nomination, Eyebuydirect continues its commitment and mission to celebrate and support unique and deserving eye care heroes who inspire day in and day out.
  • "Colleen's advocacy for eye care, positive spirit and relentless energy for overcoming obstacles is incredibly inspiring and makes her the perfect recipient of our 2022 Eye Care Award."

HelpMeSee Announces Collaboration to Fight Global Cataract Blindness

Retrieved on: 
Monday, December 19, 2022
Orbis, Life, Virtual reality, Visual impairment, The International Agency for the Prevention of Blindness, Intel, Organic, University, Power, Education, Multimedia, Orbis International, Severe cognitive impairment, Berkshire Hathaway, Partnership, Cataract, Veterinary medicine

"As we fight the global cataract blindness crisis, we celebrate this partnership and the commitment Intel has made to focus on digital transformation and tackling inequalities in healthcare," Jahani said.

Key Points: 
  • "As we fight the global cataract blindness crisis, we celebrate this partnership and the commitment Intel has made to focus on digital transformation and tackling inequalities in healthcare," Jahani said.
  • In a world where 100 million people are blind or visually impaired due to cataract, HelpMeSee works to eradicate cataract blindness using virtual reality and simulation-based training.
  • The nonprofit was founded by Al and Jim Ueltschi, who saw the opportunity to end suffering by delivering innovation from the aviation industry to the fight against cataract blindness.
  • With more than 40 simulators and 11 training centers worldwide, HelpMeSee partners with governments, universities, and innovators to fight the global cataract blindness crisis.

LG TO PRESENT ESG VISION FOR 'BETTER LIFE FOR ALL' AT CES 2023

Retrieved on: 
Monday, December 19, 2022
Collection, Quanta Computer, Inc. v. LG Electronics, Inc., Human, Voice recognition, Chilseo-myeon, Language, Reading, Commitment, Severe cognitive impairment, United Nations, GOOD, Wheelchair, Electronics, LG Electronics, GHG, Changwon, LG, Better Life, ESG, LG Corporation, CES, Renewable energy, Recycling, Planet

ENGLEWOOD CLIFFS, N.J., Dec. 19, 2022 /PRNewswire/ -- LG Electronics is spotlighting its continuing commitment to sustainability at CES® 2023, showcasing its ESG (environment-social-governance) vision and its latest impactful innovations in an exclusive exhibit dubbed the Better Life for All zone. In January 2023, CES, the world's most influential technology event, will spotlight how technology helps people tackle the world's most pressing problems in support of the United Nations efforts to advance human security for all.

Key Points: 
  • Key areas of focus for LG's ESG agenda have been built into every aspect of the CES Better Life for All zone.
  • Guides proficient in sign language will be on site, along with an LG CLOi GuideBot programmed to deliver digital-human sign language services.
  • "At LG, we are constantly challenging ourselves to go the extra mile to make our vision for a Better Life for All a reality," said Lee Jeong-seok, head of LG Electronics' Global Marketing Center.
  • LG Electronics USA, Inc., based in Englewood Cliffs, N.J., is the North American subsidiary of LG Electronics, Inc., a $63 billion global innovator in technology and manufacturing.